PDB39 Cost-Effectiveness of Saxagliptin Compared to Sitagliptin for the Treatment of Patients with Type 2 Diabetes Mellitus (T2DM)
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1342
https://www.valueinhealthjournal.com/article/S1098-3015(11)02904-4/fulltext
Title :
PDB39 Cost-Effectiveness of Saxagliptin Compared to Sitagliptin for the Treatment of Patients with Type 2 Diabetes Mellitus (T2DM)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02904-4&doi=10.1016/j.jval.2011.08.1342
First page :
A478
Section Title :
Diabetes/Endocrine Disorders
Open access? :
No
Section Order :
1293